This study is divided two parts into: Part A and Part B. Part A will recruit 24 research participants, and Part B will recruit 16 research participants.
Age range
18 Years – 70 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
The main PK parameters -Time to maximum measured plasma concentration -Tmax
Timeframe: Through study completion (approximately Day9)
Maximum observed plasma concentration-Cmax
Timeframe: Through study completion (approximately Day9)
The main PK parameters Half-life -t1/2
Timeframe: Through study completion (approximately Day9)
The main PK parameters#Area under the plasma concentration versus time curve-AUC
Timeframe: Through study completion (approximately Day9)
The main PK parameters-CL/F (apparent clearance)
Timeframe: Through study completion (approximately Day9)
The main PK parameters-Vz/F (apparent volume of distribution)
Timeframe: Through study completion (approximately Day9)
The cumulative excretion amount (Aeu)
Timeframe: Through study completion (approximately Day9)
The fraction of drug excreted in urine (Feu)
Timeframe: Through study completion (approximately Day9)
The renal clearance rate (CLR)
Timeframe: Through study completion (approximately Day9)